SIBO Uncovered: The Evidence Behind Diagnosis, Testing and Treatment

20 Jun 2026
Level 4 - Moore Room
Gut Health
Small intestinal bacterial overgrowth (SIBO) affects an estimated 30–40% of patients with IBS-type symptoms, yet it remains widely misunderstood, inconsistently diagnosed and poorly managed in clinical practice. In this session, Professor Anthony Hobson cuts through the noise surrounding SIBO, presenting the current evidence on pathophysiology, breath testing, and treatment. Attendees will leave with a clear clinical framework for identifying SIBO, IMO, and hydrogen sulphide dysbiosis, and a practical approach to transform management.
Speakers
Anthony Hobson
Anthony Hobson, Founder and Clinical Director of The Functional Gut Clinic, UK

Hosted by:

The Functional Gut Clinic
The Functional Gut Clinic
Stand: W7